EMEA (Europe, Middle East and Africa) Age-related Macular Degeneration Market Report 2018

January 2018 | 112 pages | ID: E940F8C328CEN
QYResearch

Abstracts

In this report, the EMEA Age-related Macular Degeneration market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Age-related Macular Degeneration for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Age-related Macular Degeneration market competition by top manufacturers/players, with Age-related Macular Degeneration sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer HealthCare
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Alcon
• Allergan
• Avalanche
• Bausch+Lomb
• Gilead Sciences
• Iconic Therapeutics
• Neurotech Pharmaceuticals
• Ohr Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Wet AMD
• Dry AMD

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Drugstore
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Age-related Macular Degeneration Market Report 2018

1 AGE-RELATED MACULAR DEGENERATION OVERVIEW

1.1 Product Overview and Scope of Age-related Macular Degeneration
1.2 Classification of Age-related Macular Degeneration
  1.2.1 EMEA Age-related Macular Degeneration Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Age-related Macular Degeneration Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Wet AMD
  1.2.4 Dry AMD
1.3 EMEA Age-related Macular Degeneration Market by Application/End Users
  1.3.1 EMEA Age-related Macular Degeneration Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA Age-related Macular Degeneration Market by Region
  1.4.1 EMEA Age-related Macular Degeneration Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Age-related Macular Degeneration (2013-2025)
  1.5.1 EMEA Age-related Macular Degeneration Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Age-related Macular Degeneration Revenue and Growth Rate (2013-2025)

2 EMEA AGE-RELATED MACULAR DEGENERATION COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Age-related Macular Degeneration Market Competition by Players/Manufacturers
  2.1.1 EMEA Age-related Macular Degeneration Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Age-related Macular Degeneration Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Age-related Macular Degeneration Sale Price by Players (2013-2018)
2.2 EMEA Age-related Macular Degeneration (Volume and Value) by Type/Product Category
  2.2.1 EMEA Age-related Macular Degeneration Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Age-related Macular Degeneration Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Age-related Macular Degeneration Sale Price by Type (2013-2018)
2.3 EMEA Age-related Macular Degeneration (Volume) by Application
2.4 EMEA Age-related Macular Degeneration (Volume and Value) by Region
  2.4.1 EMEA Age-related Macular Degeneration Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Age-related Macular Degeneration Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Age-related Macular Degeneration Sales Price by Region (2013-2018)

3 EUROPE AGE-RELATED MACULAR DEGENERATION (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Age-related Macular Degeneration Sales and Value (2013-2018)
  3.1.1 Europe Age-related Macular Degeneration Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Age-related Macular Degeneration Revenue and Growth Rate (2013-2018)
3.2 Europe Age-related Macular Degeneration Sales and Market Share by Type
3.3 Europe Age-related Macular Degeneration Sales and Market Share by Application
3.4 Europe Age-related Macular Degeneration Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Age-related Macular Degeneration Sales Volume by Countries (2013-2018)
  3.4.2 Europe Age-related Macular Degeneration Revenue by Countries (2013-2018)
  3.4.3 Germany Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  3.4.4 France Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  3.4.5 UK Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  3.4.6 Russia Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  3.4.7 Italy Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Age-related Macular Degeneration Sales and Growth Rate (2013-2018)

4 MIDDLE EAST AGE-RELATED MACULAR DEGENERATION (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Age-related Macular Degeneration Sales and Value (2013-2018)
  4.1.1 Middle East Age-related Macular Degeneration Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Age-related Macular Degeneration Revenue and Growth Rate (2013-2018)
4.2 Middle East Age-related Macular Degeneration Sales and Market Share by Type
4.3 Middle East Age-related Macular Degeneration Sales and Market Share by Application
4.4 Middle East Age-related Macular Degeneration Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Age-related Macular Degeneration Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Age-related Macular Degeneration Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  4.4.4 Israel Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  4.4.5 UAE Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  4.4.6 Iran Age-related Macular Degeneration Sales and Growth Rate (2013-2018)

5 AFRICA AGE-RELATED MACULAR DEGENERATION (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Age-related Macular Degeneration Sales and Value (2013-2018)
  5.1.1 Africa Age-related Macular Degeneration Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Age-related Macular Degeneration Revenue and Growth Rate (2013-2018)
5.2 Africa Age-related Macular Degeneration Sales and Market Share by Type
5.3 Africa Age-related Macular Degeneration Sales and Market Share by Application
5.4 Africa Age-related Macular Degeneration Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Age-related Macular Degeneration Sales Volume by Countries (2013-2018)
  5.4.2 Africa Age-related Macular Degeneration Revenue by Countries (2013-2018)
  5.4.3 South Africa Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Age-related Macular Degeneration Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Age-related Macular Degeneration Sales and Growth Rate (2013-2018)

6 EMEA AGE-RELATED MACULAR DEGENERATION MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer HealthCare Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Regeneron Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Alcon
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Alcon Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Allergan
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Allergan Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Avalanche
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Avalanche Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bausch+Lomb
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bausch+Lomb Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Gilead Sciences
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gilead Sciences Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Iconic Therapeutics
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Age-related Macular Degeneration Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Iconic Therapeutics Age-related Macular Degeneration Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Neurotech Pharmaceuticals
6.12 Ohr Pharmaceutical

7 AGE-RELATED MACULAR DEGENERATION MANUFACTURING COST ANALYSIS

7.1 Age-related Macular Degeneration Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Age-related Macular Degeneration

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Age-related Macular Degeneration Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Age-related Macular Degeneration Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA AGE-RELATED MACULAR DEGENERATION MARKET FORECAST (2018-2025)

11.1 EMEA Age-related Macular Degeneration Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Age-related Macular Degeneration Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Age-related Macular Degeneration Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Age-related Macular Degeneration Price and Trend Forecast (2018-2025)
11.2 EMEA Age-related Macular Degeneration Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Age-related Macular Degeneration Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Age-related Macular Degeneration Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Age-related Macular Degeneration Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Age-related Macular Degeneration Sales Forecast by Type (2018-2025)
11.7 EMEA Age-related Macular Degeneration Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Age-related Macular Degeneration
Figure EMEA Age-related Macular Degeneration Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Age-related Macular Degeneration Sales Volume Market Share by Type (Product Category) in 2017
Figure Wet AMD Product Picture
Figure Dry AMD Product Picture
Figure EMEA Age-related Macular Degeneration Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Age-related Macular Degeneration by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Age-related Macular Degeneration Market Size (Million USD) by Region (2013-2025)
Figure Europe Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Age-related Macular Degeneration Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Age-related Macular Degeneration Revenue (Million USD) Status and Forecast by Countries
Figure Africa Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Age-related Macular Degeneration Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Age-related Macular Degeneration Sales Volume and Growth Rate (2013-2025)
Figure EMEA Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Age-related Macular Degeneration Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Age-related Macular Degeneration Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Age-related Macular Degeneration Sales Share by Players (2013-2018)
Figure 2017 Age-related Macular Degeneration Sales Share by Players
Figure 2017 Age-related Macular Degeneration Sales Share by Players
Figure EMEA Age-related Macular Degeneration Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Age-related Macular Degeneration Revenue (Million USD) by Players (2013-2018)
Table EMEA Age-related Macular Degeneration Revenue Share by Players (2013-2018)
Table 2017 EMEA Age-related Macular Degeneration Revenue Share by Players
Table 2017 EMEA Age-related Macular Degeneration Revenue Share by Players
Table EMEA Age-related Macular Degeneration Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Age-related Macular Degeneration Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Age-related Macular Degeneration Sales Share by Type (2013-2018)
Figure Sales Market Share of Age-related Macular Degeneration by Type (2013-2018)
Figure EMEA Age-related Macular Degeneration Sales Market Share by Type (2013-2018)
Table EMEA Age-related Macular Degeneration Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Age-related Macular Degeneration Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Age-related Macular Degeneration by Type in 2017
Table EMEA Age-related Macular Degeneration Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Age-related Macular Degeneration Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Age-related Macular Degeneration Sales Share by Application (2013-2018)
Figure Sales Market Share of Age-related Macular Degeneration by Application (2013-2018)
Figure EMEA Age-related Macular Degeneration Sales Market Share by Application in 2017
Table EMEA Age-related Macular Degeneration Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Age-related Macular Degeneration Sales Share by Region (2013-2018)
Figure Sales Market Share of Age-related Macular Degeneration by Region (2013-2018)
Figure EMEA Age-related Macular Degeneration Sales Market Share in 2017
Table EMEA Age-related Macular Degeneration Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Age-related Macular Degeneration Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Age-related Macular Degeneration by Region (2013-2018)
Figure EMEA Age-related Macular Degeneration Revenue Market Share Regions in 2017
Table EMEA Age-related Macular Degeneration Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Age-related Macular Degeneration Revenue and Growth Rate (2013-2018)
Table Europe Age-related Macular Degeneration Sales (K Units) by Type (2013-2018)
Table Europe Age-related Macular Degeneration Market Share by Type (2013-2018)
Figure Europe Age-related Macular Degeneration Market Share by Type in 2017
Table Europe Age-related Macular Degeneration Sales (K Units) by Application (2013-2018)
Table Europe Age-related Macular Degeneration Market Share by Application (2013-2018)
Figure Europe Age-related Macular Degeneration Market Share by Application in 2017
Table Europe Age-related Macular Degeneration Sales (K Units) by Countries (2013-2018)
Table Europe Age-related Macular Degeneration Sales Market Share by Countries (2013-2018)
Figure Europe Age-related Macular Degeneration Sales Market Share by Countries (2013-2018)
Figure Europe Age-related Macular Degeneration Sales Market Share by Countries in 2017
Table Europe Age-related Macular Degeneration Revenue (Million USD) by Countries (2013-2018)
Table Europe Age-related Macular Degeneration Revenue Market Share by Countries (2013-2018)
Figure Europe Age-related Macular Degeneration Revenue Market Share by Countries (2013-2018)
Figure Europe Age-related Macular Degeneration Revenue Market Share by Countries in 2017
Figure Germany Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure France Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure UK Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Age-related Macular Degeneration Sales (K Units) by Type (2013-2018)
Table Middle East Age-related Macular Degeneration Market Share by Type (2013-2018)
Figure Middle East Age-related Macular Degeneration Market Share by Type (2013-2018)
Table Middle East Age-related Macular Degeneration Sales (K Units) by Applications (2013-2018)
Table Middle East Age-related Macular Degeneration Market Share by Applications (2013-2018)
Figure Middle East Age-related Macular Degeneration Sales Market Share by Application in 2017
Table Middle East Age-related Macular Degeneration Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Age-related Macular Degeneration Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Age-related Macular Degeneration Sales Volume Market Share by Countries in 2017
Table Middle East Age-related Macular Degeneration Revenue (Million USD) by Countries (2013-2018)
Table Middle East Age-related Macular Degeneration Revenue Market Share by Countries (2013-2018)
Figure Middle East Age-related Macular Degeneration Revenue Market Share by Countries (2013-2018)
Figure Middle East Age-related Macular Degeneration Revenue Market Share by Countries in 2017
Figure Saudi Arabia Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Age-related Macular Degeneration Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Age-related Macular Degeneration Sales (K Units) by Type (2013-2018)
Table Africa Age-related Macular Degeneration Sales Market Share by Type (2013-2018)
Figure Africa Age-related Macular Degeneration Sales Market Share by Type (2013-2018)
Figure Africa Age-related Macular Degeneration Sales Market Share by Type in 2017
Table Africa Age-related Macular Degeneration Sales (K Units) by Application (2013-2018)
Table Africa Age-related Macular Degeneration Sales Market Share by Application (2013-2018)
Figure Africa Age-related Macular Degeneration Sales Market Share by Application (2013-2018)
Table Africa Age-related Macular Degeneration Sales Volume (K Units) by Countries (2013-2018)
Table Africa Age-related Macular Degeneration Sales Market Share by Countries (2013-2018)
Figure Africa Age-related Macular Degeneration Sales Market Share by Countries (2013-2018)
Figure Africa Age-related Macular Degeneration Sales Market Share by Countries in 2017
Table Africa Age-related Macular Degeneration Revenue (Million USD) by Countries (2013-2018)
Table Africa Age-related Macular Degeneration Revenue Market Share by Countries (2013-2018)
Figure Africa Age-related Macular Degeneration Revenue Market Share by Countries (2013-2018)
Figure Africa Age-related Macular Degeneration Revenue Market Share by Countries in 2017
Figure South Africa Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Table Bayer HealthCare Age-related Macular Degeneration Basic Information List
Table Bayer HealthCare Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer HealthCare Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer HealthCare Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Bayer HealthCare Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table F. Hoffmann-La Roche Age-related Macular Degeneration Basic Information List
Table F. Hoffmann-La Roche Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure F. Hoffmann-La Roche Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Novartis Age-related Macular Degeneration Basic Information List
Table Novartis Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Novartis Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Basic Information List
Table Regeneron Pharmaceuticals Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Alcon Age-related Macular Degeneration Basic Information List
Table Alcon Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alcon Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Alcon Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Alcon Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Allergan Age-related Macular Degeneration Basic Information List
Table Allergan Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Allergan Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Allergan Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Avalanche Age-related Macular Degeneration Basic Information List
Table Avalanche Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Avalanche Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Avalanche Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Avalanche Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Bausch+Lomb Age-related Macular Degeneration Basic Information List
Table Bausch+Lomb Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bausch+Lomb Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Bausch+Lomb Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Bausch+Lomb Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Gilead Sciences Age-related Macular Degeneration Basic Information List
Table Gilead Sciences Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Sciences Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Gilead Sciences Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Gilead Sciences Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Iconic Therapeutics Age-related Macular Degeneration Basic Information List
Table Iconic Therapeutics Age-related Macular Degeneration Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Iconic Therapeutics Age-related Macular Degeneration Sales (K Units) and Growth Rate (2013-2018)
Figure Iconic Therapeutics Age-related Macular Degeneration Sales Market Share in EMEA (2013-2018)
Figure Iconic Therapeutics Age-related Macular Degeneration Revenue Market Share in EMEA (2013-2018)
Table Neurotech Pharmaceuticals Age-related Macular Degeneration Basic Information List
Table Ohr Pharmaceutical Age-related Macular Degeneration Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age-related Macular Degeneration
Figure Manufacturing Process Analysis of Age-related Macular Degeneration
Figure Age-related Macular Degeneration Industrial Chain Analysis
Table Raw Materials Sources of Age-related Macular Degeneration Major Manufacturers in 2017
Table Major Buyers of Age-related Macular Degeneration
Table Distributors/Traders List
Figure EMEA Age-related Macular Degeneration Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Age-related Macular Degeneration Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Age-related Macular Degeneration Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Age-related Macular Degeneration Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Age-related Macular Degeneration Sales Market Share Forecast by Region (2018-2025)
Table EMEA Age-related Macular Degeneration Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Age-related Macular Degeneration Revenue Market Share Forecast by Region (2018-2025)
Table Europe Age-related Macular Degeneration Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Age-related Macular Degeneration Sales Market Share Forecast by Countries (2018-2025)
Table Europe Age-related Macular Degeneration Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Age-related Macular Degeneration Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Age-related Macular Degeneration Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Age-related Macular Degeneration Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Age-related Macular Degeneration Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Age-related Macular Degeneration Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Age-related Macular Degeneration Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Age-related Macular Degeneration Sales Market Share Forecast by Countries (2018-2025)
Table Africa Age-related Macular Degeneration Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Age-related Macular Degeneration Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Age-related Macular Degeneration Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Age-related Macular Degeneration Sales Market Share Forecast by Type (2018-2025)
Table EMEA Age-related Macular Degeneration Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Age-related Macular Degeneration Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources